- Tytuł:
- Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study
- Autorzy:
- Źródło:
- In The Lancet 28 January 2023 401(10373):269-280
Czasopismo naukowe